STOCKWATCH
·
Pharmaceuticals
Quarterly Result12 Aug 2025, 01:05 pm

Zydus Lifesciences Reports Q1 FY2025 Financial Results: Net Profit at INR 3,847 Million

AI Summary

Zydus Lifesciences Ltd. has reported its unaudited financial results for the quarter ended on June 30, 2025. The company's revenue from operations stands at INR 145,901 Million, with a net profit of INR 3,847 Million. The Board of Directors approved these results in a meeting on August 12, 2025. The trading window under SEBI regulations will remain closed till August 14, 2025, and will reopen on August 18, 2025, for the Directors and Designated Persons.

Key Highlights

  • Revenue from operations for Q1 FY2025 stands at INR 145,901 Million
  • Net profit for Q1 FY2025 is INR 3,847 Million
  • Trading window to remain closed till August 14, 2025
  • Board of Directors approved the unaudited financial results on August 12, 2025
ZYDUSLIFE
Pharmaceuticals
Zydus Lifesciences Ltd

Price Impact